Lalova-Spinks Teodora, Saesen Robbe, Silva Mitchell, Geissler Jan, Shakhnenko Iryna, Camaradou Jennifer Catherine, Huys Isabelle
Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Center for IT & IP Law (CiTiP), KU Leuven, Leuven, Belgium.
Front Pharmacol. 2024 Feb 20;14:1280173. doi: 10.3389/fphar.2023.1280173. eCollection 2023.
In the European Union, the General Data Protection Regulation (GDPR) plays a central role in the complex health research legal framework. It aims to protect the fundamental right to the protection of individuals' personal data, while allowing the free movement of such data. However, it has been criticized for challenging the conduct of research. Existing scholarship has paid little attention to the experiences and views of the patient community. The aim of the study was to investigate 1) the awareness and knowledge of patients, carers, and members of patient organizations about the General Data Protection Regulation, 2) their experience with exercising data subject rights, and 3) their understanding of the notion of "data control" and preferences towards various data control tools. An online survey was disseminated between December 2022 and March 2023. Quantitative data was analyzed descriptively and inferentially. Answers to open-ended questions were analyzed using the thematic analysis method. In total, 220 individuals from 28 European countries participated. The majority were patients (77%). Most participants had previously heard about the GDPR (90%) but had not exercised any of their data subject rights. Individual data control tools appeared to be marginally more important than collective tools. The willingness of participants to share personal data with data altruism organizations increased if patient representatives would be involved in the decision-making processes of such organizations. The results highlighted the importance of providing in-depth education about data protection. Although participants showed a slight preference towards individual control tools, the reflection based on existing scholarship identified that individual control holds risks that could be mitigated through carefully operationalized collective tools. The discussion of results was used to provide a critical view into the proposed European Health Data Space, which has yet to find a productive balance between individual control and allowing the reuse of personal data for research.
在欧盟,《通用数据保护条例》(GDPR)在复杂的健康研究法律框架中发挥着核心作用。其旨在保护个人数据得到保护的基本权利,同时允许此类数据的自由流动。然而,它因对研究行为构成挑战而受到批评。现有学术研究很少关注患者群体的经历和观点。本研究的目的是调查:1)患者、护理人员和患者组织成员对《通用数据保护条例》的认识和了解;2)他们行使数据主体权利的经历;3)他们对“数据控制”概念的理解以及对各种数据控制工具的偏好。2022年12月至2023年3月期间开展了一项在线调查。对定量数据进行了描述性和推断性分析。使用主题分析法对开放式问题的答案进行了分析。共有来自28个欧洲国家的220人参与。大多数是患者(77%)。大多数参与者此前听说过GDPR(90%),但未行使过任何数据主体权利。个人数据控制工具似乎比集体工具稍微重要一些。如果患者代表参与此类组织的决策过程,参与者向数据利他组织分享个人数据的意愿会增加。研究结果凸显了提供深入数据保护教育的重要性。尽管参与者对个人控制工具略有偏好,但基于现有学术研究的思考表明,个人控制存在风险,可通过精心实施的集体工具来减轻。对结果的讨论为拟议的欧洲健康数据空间提供了批判性观点,该空间尚未在个人控制与允许将个人数据用于研究的再利用之间找到有效的平衡。